These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 35442508)

  • 21. NGAL and NGALR overexpression in human hepatocellular carcinoma toward a molecular prognostic classification.
    Zhang Y; Fan Y; Mei Z
    Cancer Epidemiol; 2012 Oct; 36(5):e294-9. PubMed ID: 22728279
    [TBL] [Abstract][Full Text] [Related]  

  • 22. HULC and H19 Played Different Roles in Overall and Disease-Free Survival from Hepatocellular Carcinoma after Curative Hepatectomy: A Preliminary Analysis from Gene Expression Omnibus.
    Yang Z; Lu Y; Xu Q; Tang B; Park CK; Chen X
    Dis Markers; 2015; 2015():191029. PubMed ID: 26136615
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The relationship among Girdin DNA methylation, its high expression, and immune infiltration in hepatocellular carcinoma: Clues from in silico analysis.
    Zhang C; Ke Y; Lei X; Liu X; Li H; Shi R; Wang L
    Biosci Rep; 2021 Mar; 41(3):. PubMed ID: 33660763
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Matrix metalloproteinase 1 is a poor prognostic biomarker for patients with hepatocellular carcinoma.
    Xu L; Yang H; Yan M; Li W
    Clin Exp Med; 2023 Oct; 23(6):2065-2083. PubMed ID: 36169759
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A morpho-molecular prognostic model for hepatocellular carcinoma.
    Srivastava S; Wong KF; Ong CW; Huak CY; Yeoh KG; Teh M; Luk JM; Salto-Tellez M
    Br J Cancer; 2012 Jul; 107(2):334-9. PubMed ID: 22713659
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Screening and verification of microRNA promoter methylation sites in hepatocellular carcinoma.
    Ni X; Lin Z; Dai S; Chen H; Chen J; Zheng C; Wu B; Ao J; Shi K; Sun H
    J Cell Biochem; 2020 Jul; 121(7):3626-3641. PubMed ID: 32065423
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Methylation-mediated repression of microRNA-129-2 suppresses cell aggressiveness by inhibiting high mobility group box 1 in human hepatocellular carcinoma.
    Liu Z; Dou C; Yao B; Xu M; Ding L; Wang Y; Jia Y; Li Q; Zhang H; Tu K; Song T; Liu Q
    Oncotarget; 2016 Jun; 7(24):36909-36923. PubMed ID: 27191994
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Oncogenic Roles of RAD51AP1 in Tumor Tissues Related to Overall Survival and Disease-Free Survival in Hepatocellular Carcinoma.
    Zhuang L; Zhang Y; Meng Z; Yang Z
    Cancer Control; 2020; 27(1):1073274820977149. PubMed ID: 33269607
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Transcriptional analysis of the expression, prognostic value and immune infiltration activities of the COMMD protein family in hepatocellular carcinoma.
    Wang X; He S; Zheng X; Huang S; Chen H; Chen H; Luo W; Guo Z; He X; Zhao Q
    BMC Cancer; 2021 Sep; 21(1):1001. PubMed ID: 34493238
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Revealing the clinical significance and prognostic value of small nucleolar RNA SNORD31 in hepatocellular carcinoma.
    Ding Y; Sun Z; Zhang S; Xu Q; Zhou L; Zhou D; Li Y; Han X; Xu H; Bai Y; Xu C; Ding H; Ge Y; Wang W
    Biosci Rep; 2020 Jul; 40(7):. PubMed ID: 32697317
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Bioinformatics on vascular invasion markers in hepatocellular carcinoma via Big-Data analysis].
    Chen Q; Qiu XQ
    Zhonghua Liu Xing Bing Xue Za Zhi; 2017 Apr; 38(4):522-527. PubMed ID: 28468075
    [No Abstract]   [Full Text] [Related]  

  • 32. High expression of PARD3 predicts poor prognosis in hepatocellular carcinoma.
    Li S; Huang J; Yang F; Zeng H; Tong Y; Li K
    Sci Rep; 2021 May; 11(1):11078. PubMed ID: 34040099
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Overexpression of TONSL might be an independent unfavorable prognostic indicator in hepatocellular carcinoma.
    Yu B; Ding Y; Liao X; Wang C; Wang B; Chen X
    Pathol Res Pract; 2019 May; 215(5):939-945. PubMed ID: 30723051
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cyclin-dependent kinase 19 upregulation correlates with an unfavorable prognosis in hepatocellular carcinoma.
    Cai X; Deng J; Zhou J; Cai H; Chen Z
    BMC Gastroenterol; 2021 Oct; 21(1):377. PubMed ID: 34649520
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Methylation of tissue factor pathway inhibitor 2 as a prognostic biomarker for hepatocellular carcinoma after hepatectomy.
    Sun FK; Sun Q; Fan YC; Gao S; Zhao J; Li F; Jia YB; Liu C; Wang LY; Li XY; Ji XF; Wang K
    J Gastroenterol Hepatol; 2016 Feb; 31(2):484-92. PubMed ID: 26313014
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Integrated analysis identifies a long non-coding RNAs-messenger RNAs signature for prediction of prognosis in hepatitis B virus-hepatocellular carcinoma patients.
    Bai Z; Li H; Li C; Sheng C; Zhao X
    Medicine (Baltimore); 2020 Oct; 99(40):e21503. PubMed ID: 33019382
    [TBL] [Abstract][Full Text] [Related]  

  • 37. RUNX2 promotes hepatocellular carcinoma cell migration and invasion by upregulating MMP9 expression.
    Wang Q; Yu W; Huang T; Zhu Y; Huang C
    Oncol Rep; 2016 Nov; 36(5):2777-2784. PubMed ID: 27666365
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Integrated analysis of methylation-driven genes and pretreatment prognostic factors in patients with hepatocellular carcinoma.
    He D; Liao S; Cai L; Huang W; Xie X; You M
    BMC Cancer; 2021 May; 21(1):599. PubMed ID: 34034705
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identification of a Liver Progenitor Cell-Related Genes Signature Predicting Overall Survival for Hepatocellular Carcinoma.
    Li X; Lin J; Pan Y; Cui P; Xia J
    Technol Cancer Res Treat; 2021; 20():15330338211041425. PubMed ID: 34866477
    [No Abstract]   [Full Text] [Related]  

  • 40. SYPL1 overexpression predicts poor prognosis of hepatocellular carcinoma and associates with epithelial-mesenchymal transition.
    Chen DH; Wu QW; Li XD; Wang SJ; Zhang ZM
    Oncol Rep; 2017 Sep; 38(3):1533-1542. PubMed ID: 28731154
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.